Abstract: The present invention relates to a screening method to identify individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53; which comprises the steps of: a) obtaining a biological sample from said patients; and b) determining the presence of p53pro or p53arg wildtype alleles in said sample; wherein the allele pattern of patients selected from the group consisting of p53pro/p53pro, p53arg/p53arg and p53pro/p53arg are indicative of a risk factor for developing disease associated with different polymorphic forms of wildtype p53. Notably, individuals who are p53arg/arg are at greater risk of developing pathologies associated with human papillomavirus infections, including cervical cancer.
Type:
Grant
Filed:
March 1, 2000
Date of Patent:
December 3, 2002
Assignees:
McGill University, Imperial Cancer Research Technology, International Center for Genetic Engineering and
Biotechnology
Inventors:
Greg J. Matlashewski, Lawrence Banks, Alan Storey